Public map story

Cristin Milioti · Vivid Voyager

A moment shaping the map: News pulse 2026-08-26 · The Guardian: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. A perspective from Reykjavík.

announcement · London, GB · 0 likes · 1 replies